Research map: Integrating Vadadustat into Pharmaceutical Care for CKD-Related Anemia: Evidence-Based and Pharmacovigilance Perspectives

Back to the article

Papers in this map

  1. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease · Ajay Singh · 2006 · 2779 citations · Cited by this paper
  2. Assessment of Muscle Mass and Diagnosis of Sarcopenia in Peritoneal Dialysis Patients · 2026 · Related
  3. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease · Marc A. Pfeffer · 2009 · 2111 citations · Cited by this paper
  4. Socioeconomic Status and Kidney Disease · 2026 · Related
  5. Mechanisms of thyroid hormone action · Gregory A. Brent · 2012 · 1257 citations · Cited by this paper
  6. Tissue Inhibitor of Metalloproteinases-2 (TIMP2) Affects Allograft Function in Incident Kidney Transplant Recipients · 2025 · Related
  7. Mechanisms of Anemia in CKD · Jodie L. Babitt · 2012 · 1018 citations · Cited by this paper
  8. Comparative Analysis of ChatGPT and Gemini in Addressing Questions from Chronic Kidney Disease Patients · 2026 · Related
  9. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD · Nupur Gupta · 2017 · 452 citations · Cited by this paper
  10. Residual Kidney Function and the Impact of Dialysis Modality · 2025 · Related
  11. Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents · José María Portolés · 2021 · 373 citations · Cited by this paper
  12. Modality of Dialysis and Gastrointestinal Symptoms: A Cross-Sectional Study in Jordanian Adults · 2025 · Related
  13. A Gain-of-Function Mutation in the HIF2A Gene in Familial Erythrocytosis · Melanie J. Percy · 2008 · 317 citations · Cited by this paper
  14. Normative Values and Clinical Correlations of Handgrip Strength in Chronic Kidney Disease Patients Undergoing Hemodialysis: A Multicenter Colombian Study · 2025 · Related
  15. Epidemiology of peritoneal dialysis outcomes · Aminu K. Bello · 2022 · 272 citations · Cited by this paper
  16. Successful Dialysis Weaning in Refractory Membranous Nephropathy Through Long-Term Multi-Disciplinary Management: A Case Report · 2026 · Related
  17. Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD · Glenn Matthew Chertow · 2021 · 253 citations · Cited by this paper
  18. Gender Medicine in Nephrology: From Biological Mechanisms to Clinical Inequities · 2026 · Related
  19. Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease · Pablo E. Pérgola · 2016 · 237 citations · Cited by this paper
  20. The Increase in Kidney Biopsies in Germany—Potential Risks and Reasons · 2026 · Related
  21. Basics and principles of cellular and systemic iron homeostasis · Angeliki Katsarou · 2020 · 212 citations · Cited by this paper
  22. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis · Kai‐Uwe Eckardt · 2021 · 211 citations · Cited by this paper
  23. Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease · Volker H. Haase · 2021 · 192 citations · Cited by this paper
  24. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference · Elaine Ku · 2023 · 144 citations · Cited by this paper
  25. Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease · Edouard R. Martin · 2017 · 128 citations · Cited by this paper
  26. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review · F Al Raiisi · 2019 · 121 citations · Cited by this paper
  27. The ERA Registry Annual Report 2019: summary and age comparisons · Rianne Boenink · 2021 · 119 citations · Cited by this paper
  28. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data · Heleen van Haalen · 2020 · 109 citations · Cited by this paper
  29. Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients · Connie M. Rhee · 2014 · 103 citations · Cited by this paper
  30. Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management · Krzysztof Badura · 2024 · 100 citations · Cited by this paper
  31. Evidence-based pharmaceutical care: The next chapter in pharmacy practice · Osama M. Al-Quteimat · 2014 · 93 citations · Cited by this paper
  32. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review · Bruce Spinowitz · 2019 · 83 citations · Cited by this paper
  33. Revealing a Mutant-Induced Receptor Allosteric Mechanism for the Thyroid Hormone Resistance · Benqiang Yao · 2019 · 82 citations · Cited by this paper
  34. The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD · M. Alan Brookhart · 2008 · 75 citations · Cited by this paper
  35. Regulation of Erythropoiesis by the Hypoxia-Inducible Factor Pathway: Effects of Genetic and Pharmacological Perturbations · Gregg L. Semenza · 2022 · 72 citations · Cited by this paper
  36. Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis · Marie Evans · 2020 · 71 citations · Cited by this paper
  37. Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study · Masaomi Nangaku · 2021 · 67 citations · Cited by this paper
  38. Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients · Masaomi Nangaku · 2020 · 46 citations · Cited by this paper
  39. Roxadustat and thyroid-stimulating hormone suppression · Atsuyuki Tokuyama · 2021 · 45 citations · Cited by this paper

Source: OpenAlex (CC0)